Ming Hua Qi

Summary

Country: China

Publications

  1. ncbi [Escitalopram for intervention of psychiatric adverse events during peginterferon-alfa-2a and ribavirin treatment for chronic hepatitis C]
    Minghua Qi
    Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China
    Nan Fang Yi Ke Da Xue Xue Bao 33:1012-6. 2013

Detail Information

Publications1

  1. ncbi [Escitalopram for intervention of psychiatric adverse events during peginterferon-alfa-2a and ribavirin treatment for chronic hepatitis C]
    Minghua Qi
    Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China
    Nan Fang Yi Ke Da Xue Xue Bao 33:1012-6. 2013
    ..To evaluate the risk factors of psychiatric adverse events associated with PEG interferon and ribavirin treatment for chronic hepatitis C and assess the efficacy of escitalopram intervention for these adverse effects...